Carlsmed COO Jeffrey Bertolini files initial beneficial ownership statement
CARL•Initial ownership filing
Carlsmed COO Jeffrey Bertolini filed an initial ownership statement showing 22,489 common shares.
The disclosure also lists stock options covering 64,184 shares, with exercise prices of $15, $5.92, and $2.23.
